Form 4: Agilent Director Boosts Stake with Stock Acquisition

Agilent Technologies Director Mikael Dolsten acquired 2,158 shares of common stock at $111.75 per share, with a portion deferred, and additional shares via dividend reinvestment, increasing total beneficial ownership to 7,138.21 shares.

Summary

• Mikael Dolsten, a Director at Agilent Technologies, Inc. (A), acquired 2,158 shares of common stock.
• The transaction occurred on March 19, 2026, at a price of $111.75 per share.
• These shares were part of an award for Non-Employee Directors and were fully vested upon grant.
• Mr. Dolsten elected to defer the receipt of 1,079 of these shares.
• An additional 7.182 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan, also deferred.
• Following these transactions, Mr. Dolsten's beneficial ownership stands at 7,138.21 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal. While the acquisition is part of an award and dividend reinvestment, it represents an increase in a director's beneficial ownership, which generally indicates confidence in the company's long-term value.

Positives

• A Director increasing their stake in the company can signal confidence in future performance.
• The acquisition was part of a fully vested award, indicating a structured compensation component for directors.
• Participation in the dividend reinvestment plan further demonstrates a long-term commitment to the company's equity.

Future Outlook

This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by directors, are often interpreted by the market as a positive signal, suggesting that those closest to the company believe its stock is undervalued or has strong future prospects. While this specific transaction is part of an award and dividend reinvestment, it still reflects a director's increasing stake in the company.

Comparison to Industry Standards

• This filing reports an insider transaction, which is not typically compared to industry-wide financial performance benchmarks.
• The practice of non-employee directors receiving equity as part of their compensation is a standard corporate governance practice across many industries, including the life sciences and diagnostics sector where Agilent operates.
• The decision to defer shares is also a common strategy for long-term wealth accumulation and tax planning among executives and directors.

Related Party Transactions

• The acquisition of shares by a director as part of an award and through a dividend reinvestment plan constitutes a transaction between the company and a related party (the director). This is a standard form of compensation and share accumulation for directors.

Stakeholder Impact

• Shareholders: May view the director's increased stake as a positive indicator of management's confidence in the company's future.

Key Dates

Recommendation

While a single insider acquisition, even through an award and dividend reinvestment, is generally a positive signal indicating a director's confidence, it is typically not sufficient on its own to warrant a 'buy' recommendation. It reinforces a 'hold' position for existing investors and suggests continued monitoring for potential investors, as it aligns the director's interests with long-term shareholder value.

Keywords

Agilent Technologies, A, Mikael Dolsten, Director, Insider Transaction, Form 4, Stock Acquisition, Common Stock, Equity, 10b5-1 Plan, Dividend Reinvestment